Navigation Links
DURECT Corporation to Participate in Upcoming Healthcare Conferences
Date:8/31/2011

CUPERTINO, Calif., Aug. 31, 2011 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today that management is scheduled to present at three upcoming healthcare conferences.

(Logo:  http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

  • Jim Brown, President and CEO, will present at the Stifel Nicolaus Healthcare Conference in Boston on Thursday, September 8 at 3:50 p.m. Eastern Time. A live audio webcast of the presentation will be available by accessing http://www.veracast.com/webcasts/stifel/healthcare2011/19213681.cfm.
  • Matt Hogan, Chief Financial Officer, will present at the Rodman & Renshaw Life Sciences Conference in New York on Monday, September 12 at 10:40 a.m. Eastern Time.  A live audio webcast of the presentation will be available by accessing http://www.wsw.com/webcast/rrshq20/drrx .
  • Matt Hogan will also present at the UBS Global Life Sciences Conference in New York on Monday, September 19 at 3:00 p.m. Eastern Time.  A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations."  If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, trans
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
2. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
3. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
4. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
5. DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
6. DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call
7. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
8. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT to Present at the Barclays Capital Global Healthcare Conference
11. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Calif. , July 28, 2015  Leaf ... burden that pressure ulcers place on the healthcare ... a leading threat to modern quality healthcare. Research ... Services, Agency for Healthcare Research and Quality shows ... more than $11 billion a year. The condition ...
(Date:7/28/2015)... July 28, 2015 Mike Rowe , spokesperson ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference ... in Las Vegas, Nev. ... Gotta Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe ... nation,s  "unsung heroes" – people whose hard work, sacrifice and ...
(Date:7/28/2015)... DURHAM, N.C. , July 28, 2015 ... of equity financing totaling $13 million. The oversubscribed round ... LLC (managers of the Duke endowment), Cunning Capital, Triad, ... the North Carolina Biotechnology Center. Many of Advanced Liquid ... Baebies, executive team, also invested. "Rex ...
Breaking Medicine Technology:Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2
... , , ALISO VIEJO, Calif., Dec. 21 Clarient, Inc. ... for pathologists, oncologists and the pharmaceutical industry, today announced that ... (AGI) in an all-stock merger valued at up to $17.6 ... merger agreement are successfully met. As a result of ...
... , HONG KONG and PHILADELPHIA, Dec. 21 The University ... Thomson Reuters to reduce author ambiguity and enhance the robustness ... open access support to the university,s scholarly content. HKU, Hong ... ResearcherID on this scale with more than 900 ...
Cached Medicine Technology:Clarient Acquires Applied Genomics, Inc. 2Clarient Acquires Applied Genomics, Inc. 3Clarient Acquires Applied Genomics, Inc. 4Clarient Acquires Applied Genomics, Inc. 5Clarient Acquires Applied Genomics, Inc. 6Clarient Acquires Applied Genomics, Inc. 7The University of Hong Kong Chooses ResearcherID By Thomson Reuters to Standardize Research Identifiers 2The University of Hong Kong Chooses ResearcherID By Thomson Reuters to Standardize Research Identifiers 3
(Date:7/29/2015)... Scottsdale, Arizona (PRWEB) , ... July 29, 2015 , ... ... residential dorms. The project, which will by the end will cost the 501(c) organization ... compliance of Arizona’s recent anti-ligature requirements. , “We took it down to the ...
(Date:7/29/2015)... ... July 29, 2015 , ... National non-profit World ... life insurance, annuities, employee benefits and asset management, has joined as presenting sponsor ... taking place in Charlotte, North Carolina on October 2-4, 2015. , Hosted at ...
(Date:7/29/2015)... ... July 29, 2015 , ... Indiana is known for basketball, the boyhood ... of Zerorez Indianapolis, which plans to expand across the state. , Ray Kennedy, owner ... full year in business and we should double our first year’s revenue. More ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... ... July 29, 2015 , ... ITW Dynatec, along with ... role, Powers is responsible for driving growth and innovation across ITW Dynatec’s worldwide ... record as an effective leader within the ITW community speaks for itself. We ...
Breaking Medicine News(10 mins):Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3
... , , WARRENVILLE, Ill., Aug. 5 ... ) is reaching out to key members of Congress to offer ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090804/UCAOALOGO ) ... care is a critical part of any patient-centered health care system, ...
... , , , ... Barrett has been elected to the company,s board of directors and will ... the completion of the planned spinoff of CareFusion Corp. on Aug. 31. ... chief executive officer of the company,s Healthcare Supply Chain Services segment since ...
... , Sen. Sherrod Brown, Public Health Insurance ... Reform Stand, Need To Hold Insurers Accountable , , ... will join health care expert Jacob Hacker and Campaign for ... call Thursday morning to brief reporters on a new analysis that shows ...
... , , BOSTON, Aug. ... a proposed $41.5 million settlement with drug manufacturers Merck & ... SGP ) to settle allegations the companies suppressed ... Vytorin and Zetia. Merck and Schering-Plough previously settled similar ...
... MaxLife Fund Corp. (OTC:MXFD), have announced that some of ... of 14,050,000 shares of the Company,s common stock in ... , Bennett Kurtz, Chief Executive Officer of the Company ... for our Company to increase shareholder value and support ...
... ... of prime labels with new site enhancements. The site enhancements provide customers with a ... , ... (PRWEB) August 5, 2009 -- My1Stop.com, the commercial printing superstore, launched upgraded prime label ...
Cached Medicine News:Health News:Urgent Care Association of America Launches Program to Educate Congress on Urgent Care 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 2Health News:George Barrett Named Chairman and CEO of Cardinal Health 3Health News:George Barrett Named Chairman and CEO of Cardinal Health 4Health News:Sen. Brown, Hacker, to Release New Paper On How Public Plan in House and Senate Bills Measure Up 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 2Health News:Hagens Berman Sobol Shapiro: Vytorin and Zetia Makers Settle Class-Action Suit With Proposed $41.5 Million 3Health News:MaxLife Fund Corp. announces cancellation of 14,050,000 Common Shares 2Health News:My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design 2
... for use with Coulter® Ac.T™ three-part ... diluent, lysing agent, cleaning agent and ... package configuration includes diluent, lysing agent, ... shelf life is one year from ...
... reagent manufactured for the ... hemoglobin and white blood ... is manufactured specifically for ... CELL-DYN® 1700. The shelf ...
... an enzymatic cleanser for automated and semi-automated ... 475ml bottle has a flip-top spout for ... that require manual addition of an enzyme ... of this product. The shelf life of ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Medicine Products: